Although it may seem like a new technology, telemedicine—or the delivery of a healthcare service or information using telecommunications—has been an innovation in motion for decades. In fact, it has been disrupting the way patients experience care for more than 40 years and is increasingly being integrated throughout today’s healthcare delivery systems. While telemedicine might […]
Join us July 12-13 in Philadelphia at the healthcare industry’s must-attend innovation event, MedCity CONVERGE. CONVERGE gathers the entire B2B healthcare ecosystem to talk in real-term, actionable ways about healthcare’s biggest challenges and opportunities. We’ll focus on the leading trends and hot button topics that include these panel presentations and many others: Panel Presentation: What […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Interest in telehealth continues to rise in U.S. healthcare organizations. The global telemedicine market is poised to grow to $34B by 2020. Health systems are increasingly incorporating telehealth into their everyday practices. Telehealth deployments run the spectrum from acute treatment of minor illness, rashes, strains and infections, to more advanced specialty use cases such as cardiology, radiology, […]
Ed. note: This post is sponsored by the American Telemedicine Association. There’s no doubt that telemedicine is growing: Its usage is up 50 percent since 2013 with nearly 15 million people using such services in 2015. Here are the top five telemedicine trends happening right now. […]
This is the second post of a 3 part series discussing telemedicine sponsored by American Well. CMS recently unveiled a massive regulatory overhaul of Medicaid managed care requirements, which includes a call for states to allow telehealth to meet network adequacy standards. Historically, telehealth has been left out of this equation. The telehealth world is still evolving, […]
This is the first post of a 3 part series discussing telemedicine sponsored by American Well. A recent study by Willis Towers Watson found that telehealth could save as much as $6 billion annually in U.S. healthcare costs. While this figure indicates huge potential within healthcare systems for reducing medical costs with telehealth, it’s equally […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Providers are realizing that patients are customers, and healthcare services have to be tailored to their diverse needs and circumstances. Personalized medicine is gaining steam. Does the same personalized approach work for patient-facing mobile apps? While 66 out of the 100 largest US hospitals offer branded apps, only 2% of patients are using them, according […]
Ed. note: This post is sponsored by the American Telemedicine Association. What does the telemedicine industry look like now? And where do the greatest opportunities lie – that is, if some big-time barriers don’t stand in the way? For an inside look at the industry, we asked some of telemedicine’s top CEOs these questions and […]
This is a three-part series focusing on the role vitamin and mineral supplements can play in supplementing essential vitamins and minerals Americans may not be getting from diet alone. Part 1 of this series described the debate over the role vitamin and mineral supplements (VMS) may play in reducing the risks for various chronic diseases and how […]
This post is sponsored by eyeforpharma. The definition of pharma needs to be rewritten. Why? Your pharma company is not just drug developer anymore. In the new consumer-driven health economy, pharma’s new role is that of a health care player. Thus, the industry needs to find the next commercial model that guarantees their organization as […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Join us in Chicago on April 12-13, 2016 for MedCity INVEST, the premier national healthcare investing conference based in the Midwest. Register by 4/4 for the extended early bird rate. MedCity INVEST unites active investors and corporate development execs with healthcare’s most promising startups from the biotech, medical device, digital health, diagnostics, pharma, and regenerative medicine […]
Ed. note: This post is sponsored by the American Telemedicine Association. Maryland and New Hampshire drop a letter grade, while New York, Nevada and others step up. Since the American Telemedicine Association began its annual reports in 2014 grading states on their telemedicine access, some states have maintained steady grades. But others have seen their […]
This independent editorial series on healthcare and the law is sponsored by Lake Whillans, a distressed venture capital and litigation finance firm that helps companies facing litigation or arbitration. As states began to jump onto the pharmaceutical regulation bandwagon around the turn of the century, Porzio Bromberg & Newman brought John Ohoro on to help clients sift […]
MedCity INVEST – April 12-13 in Chicago At MedCity INVEST, active investors connect with corporate business development executives to facilitate investment opportunities with over 40 of the most promising healthcare start-ups that span the biotech, medical device, digital health, diagnostics, pharma, and regenerative medicine sectors Over 300 healthcare experts, industry leaders, active investors and entrepreneurs […]
Not too long ago, it didn’t take much for someone with an idea for a new medical device to rake in the early-stage funding. Investors have been a bit more discerning over the past decade, to say the least, and by and large they remain so, according to K&L Gates’ Michael Hedge, who’s been around long enough to […]